New Blood Test and Screening Protocol Reduces Unnecessary Prostate Biopsies
A new prostate cancer screening protocol known as PROscreenMRI, developed by the Candiolo Cancer Institute IRCCS and Piedmontese partners, avoids up to 63% of unnecessary prostate biopsies. By integrating prostate-specific … Read More